Höffken K, Price M R, Moore V E, Baldwin R W
Int J Cancer. 1978 Nov 15;22(5):576-82. doi: 10.1002/ijc.2910220512.
Sera from rats bearing intraperitoneal implants of an aminoazo dye-induced hepatoma were fractionated by Sephadex G200 and DEAE-cellulose ion exchange column chromatography. Isolated fractions were examined for their capacity to bind [125I]C1q as a measure of immune complex levels, and for their ability to bind soluble tumour-specific antigen as well as to react with antigens expressed at the surface of viable hepatoma cells. Elevated levels of circulating immune complexes in unfractionated serum were directly detectable during early tumour development although, following serum fractionation, immune complexes were identified at both early and late stages of tumour growth. The present findings suggest that the detection of immune complexes in unfractionated samples of late tumour-bearer serum using a C1q-binding assay is masked by the increasing production of tumour-specific antibodies and by a shift from complement fixing to non-complement-fixing tumour-specific antibodies.
通过葡聚糖凝胶G200和二乙氨基乙基纤维素离子交换柱色谱法对腹腔植入氨基偶氮染料诱导的肝癌大鼠的血清进行分级分离。检测分离出的级分结合[125I]C1q的能力,以此作为免疫复合物水平的指标,并检测其结合可溶性肿瘤特异性抗原以及与活肝癌细胞表面表达的抗原发生反应的能力。在肿瘤早期发展过程中,直接可检测到未分级血清中循环免疫复合物水平升高,不过,血清分级分离后,在肿瘤生长的早期和晚期均鉴定出免疫复合物。目前研究结果表明,使用C1q结合试验检测晚期荷瘤大鼠血清未分级样品中的免疫复合物,会被肿瘤特异性抗体产量增加以及从补体结合性肿瘤特异性抗体向非补体结合性肿瘤特异性抗体的转变所掩盖。